Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology (United Kingdom)

Volumn 54, Issue 6, 2015, Pages 964-971

  Druce, Katie L ^a   Jones, Gareth T ^a   Macfarlane, Gary J ^a   Basu, Neil ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti TNF; Fatigue; Rheumatoid arthritis

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; STEROID; THYROXINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; DISABILITY; FATIGUE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; UNEMPLOYMENT;

EID: 84938539802     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu390     Document Type: Article

References (51)

1. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology 2006;45:885-9.
2. Jump RL, Fifield J, Tennen H, Reisine S, Giuliano AJ. History of affective disorder and the experience of fatigue in rheumatoid arthritis. Arthritis Care Res 2004;51: 239-45.
3. Hewlett S, Nicklin J, Treharne GJ. Fatigue in Musculoskeletal Conditions. Reports on the Rheumatic Diseases (Series 6). Topical Reviews 1. Chesterfield, UK: Arthritis Research Campaign, 2008.
4. Suurmeijer TPBM, Waltz M, Moum T et al. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Care Res 2001;45:111-21.
5. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GAM. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Care Res 2004;51:578-85.
6. Moreland LW, Genovese MC, Sato R, Singh A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Care Res 2006;55:287-93.
7. Aaronson LS, Teel CS, Cassmeyer V et al. Defining and measuring fatigue. J Nurs Sch 1999;31:45-50.
8. Arend WP. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Care Res 2001;45:101-6.
9. Patarca R. Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 2001;933:185-200.
10. Epstein FH, Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
11. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-42.
12. Aouizerat BE, Dodd M, Lee K et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009;11:27-41.
13. Norheim KB, Jonsson G, Omdal R. Biological mechanisms of chronic fatigue. Rheumatology 2011;50:1009-18.
14. Sheng WS, Hu S, Lamkin A, Peterson PK, Chao CC. Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice. Clin Immunol Immunopathol 1996;81:161-7.
15. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994;18(Suppl 1): S147-53.
16. Weinblatt ME, Keystone EC, Furst DE et al. Adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003;48:35-45.
17. Yount S, Sorensen MV, Cella D et al. Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis. Clin Exp Rheumatol 2007;25: 838-46.
18. Chauffier K, Salliot C, Berenbaum F, Sellam J. Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis. Rheumatology 2012;51:60-8.
19. Maini RN, Breedveld FC, Kalden JR et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004;50: 1051-65.
20. Watson K, Symmons D, Griffiths I, Silman A. The British Society for Rheumatology biologics register. Ann Rheum Dis 2005;64(Suppl 4):iv42-3.
21. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
22. Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Care Res 2007;57:429-39.
23. Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Rheumatology 1998; 37:425-36.
24. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. conceptual framework and item selection. Med Care 1992;30:473-83.
25. Wiles N, Symmons DPM, Harrison B et al. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 2001;42:1339-46.
26. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2001;43:1478-87.
27. Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2007;13(Suppl 9):s237-51.
28. Jones GT, Beasley M, Atzeni F et al. The prevalence of fibromyalgia in the general population-a comparison of the ACR 1990, 2010 and modified 2010 classification criteria. Arthritis Rheum 2013;65(Suppl):S358.
29. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Rheumatology 1986;25: 206-9.
30. Bruce B, Fries J. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003;1:20.
31. Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for Severity, Effect, and Coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res 2011;63(Suppl 11): S263-86.
32. Linden A. Assessing regression to the mean effects in health care initiatives. BMC Med Res Methodol 2013;13: 1-7.
33. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215-20.
34. Hewlett S, Chalder T, Choy E et al. Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology 2011;50:1004-6.
35. Erickson SR, Williams BC, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens 2001;15:539-48.
36. van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology 2010;49:1294-302.
37. Coury F, Rossat A, Tebib A et al. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol 2009;36:58-62.
38. Fifield J, Tennen H, Reisine S, McQuillan J. Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41:1851-7.
39. Hazes JM, Taylor P, Strand V et al. Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol. Rheumatology 2010;49:1900-10.
40. Mancuso CA, Paget SA, Charlson ME. Adaptations made by rheumatoid arthritis patients to continue working: a pilot study of workplace challenges and successful adaptations. Arthritis Care Res 2000;13:89-99.
41. Cutolo M, Sulli A, Capellino S et al. Anti-TNF and sex hormones. Ann NY Acad Sci 2006;1069:391-400.
42. Kristensen LE, Kapetanovic MC, Gülfe A et al. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology 2008;47:495-9.
43. Thyberg I, Dahlstrom O, Thyberg M. Factors related to fatigue in women and men with early rheumatoid arthritis: the Swedish TIRA study. J Rehabil Med 2009;41:904-12.
44. Sokka T, Toloza S, Cutolo M et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009;11:R7.
45. Treharne GJ, Lyons AC, Hale ED et al. Predictors of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med 2008;13:494-504.
46. Mancuso CA, Rincon M, Sayles W, Paget SA. Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006;33:1496-502.
47. van Dartel SAA, Repping-Wuts JWJ, van Hoogmoed D et al. Association between fatigue and pain in rheumatoid arthritis: does pain precede fatigue or does fatigue precede pain? Arthritis Care Res 2013;65:862-9.
48. Nijrolder I, van der Windt DA, Twisk JW, van der Horst HE. Fatigue in primary care: longitudinal associations with pain. Pain 2010;150:351-7.
49. Bergman M, Shahouri S, Shaver T et al. Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol 2009;36:2788-94.
50. Stebbings S, Herbison P, Doyle TCH, Treharne GJ, Highton J. A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. Rheumatology 2010;49:361-7.
51. Hewlett S, Cockshott Z, Byron M et al. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Care Res 2005;53:697-702.